See also this year's filing and all EDGAR filings for this company.
PDF Report 0001113148_2020_Infinity_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001113148, Infinity Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 44,581,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,186,000 |
| 3 | remainder_Assets | 2,247,000 |
| 4 | LiabilitiesCurrent | 9,698,000 |
| 5 | LiabilitiesNoncurrent | 1,964,000 |
| 6 | remainder_Liabilities | 29,626,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,298,759 |
| 9 | ResearchAndDevelopmentExpense | 28,746,717 |
| 10 | remainder_Expenses | 42,804,548 |
| 11 | remainder_Revenues | 16,107,880 |
| 12 | remainder_NetIncome | -804,955 |
| 13 | remainder_ComprehensiveNetIncome | 15,749 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 49,014,000 |
| 1 | Liabilities | 41,288,000 |
| 2 | Expenses | 85,850,024 |
| 3 | Revenues | 16,107,880 |
| 4 | StockholdersEquity | 7,726,000 |
| 5 | NetIncome | -70,547,099 |
| 6 | ComprehensiveNetIncome | -70,539,224 |
| 7 | BaseVar | 96,540,304 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.19 |
| 9 | EconomicCapitalRatio | 1.26 |
Edgar->Model Mapping
Feature Distribution
Change over Time
